amino acid disorders + urea cycle disorders + lipid disorders Flashcards
amino acid disorders discussed in this class
phenylketonuria (PKU)
maple syrup urine disease (MUSD)
alkaptonuria
PKU inheritance + general
autosomal recessive
impaired ability to metabolize phenylalanine
PKU genetic abnormality
mutations involving loci encoding for PAH on chromosome 12q
mutations include substitutions, insertions, deletions
PKU
enzyme affected
phenylalanine hydroxylase (PAH)
PKU
effect on substrate/byproduct
buildup of phenylalanine
PKU
pathophys
elevated levels of plasma phenylalanine that disrupts essentail cellular proccesses in the brain and eventually causes mental retardation
PKU levels of phenylalanine are 6-80 mg/dl (normal is 1 mg/dl)
PKU
clinical manifestations
untreated PKU has severe mental retardation
normal at birth then progressive developmetnaly delay
must catch early and control
PKU
expression/penetrance
disease freq. varies by population
turkey has high incidence rate
high in yeminite jewish populaiton, northern/eastern europe, italy, and china
PKU treatment
restoring normal blood phe levels thru restricting dietary phe
strong relationship exists between control of blood phe levels in childhood and IQ
rare autosomal recessive diorder that involves defects in catabolic pathway of branched chain amino acids
maple syrup urine disease
MUSD
genetic abnormality
caused by mutaiton of 1 of 6 loci that envode for the branched chain amino acid complex (BCKAD complex)
BCKAD complex
composed of 4 catalytic components and 2 regulatory enzymes
most mutations occur in the catalytic compenent section
normally involved in decarboxylation of alpha keto acids of branched chain AAs to their acyl-CoA
MUSD
enzyme affected
BCKAD Complex
branched chain amino acids
leucine, isoleucine, valine
effect on substrate/byproduct
MUSD
accumulation of branched chain amino acids (valine, leucine, isoleucine)
leucine accumulation
neurological symptoms bc it is transported rapidly across BBB and metabolized to yield presumably glutamate and glutamine
elevation of plasma isoleucine…
maple syrup odor of urine
clinical manifestation of MSUD
accumulation of any of the 3 AA leads to encephalopathy and progressive neurodegeneration in infants not treated
poor feeding, vomiting, failure to thrive, increased lethargy
MSUD expression and prevalance
more prevalant in populations with high frequency of consanguinity
ex. mennonite community of Lancaster County, PA
symptoms devleop in neonates aged 4-7 days
variability
MSUD
treatment
early diagnosis and diet intervention to prevent complications and allow normal IQ
dietary restriction of branched chain AAs to only what is minimally needed
thiamine supplement
Alkapotnuria
Genetic abnormality
HGO gene
defect in catabolic pathway of tyrosine
intermediate product of tyrosine catabolic pathway
homogentisic acid
Alkapotnuria
enzyme affected
deficiency of HGO
Alkapotnuria
effect on substrate/byproduct
deficiency of HGO causes accumulation of homogentisic acid
homogentisic acid is rapidly cleared in kidney and excreted